Jci_page_head_homepage_01 Jci_page_head_homepage_02
James Cantley, Colin Selman, Deepa Shukla, Andrey Y. Abramov, Frauke Forstreuter, Miguel A. Esteban, Marc Claret, Steven J. Lingard, Melanie Clements, Sarah K. Harten, Henry Asare-Anane, Rachel L. Batterham, Pedro L. Herrera, Shanta J. Persaud, Michael R. Duchen, Patrick H. Maxwell, Dominic J. Withers
Published in Volume 119, Issue 1
J Clin Invest. 2009; 119(1):125–135 doi:10.1172/JCI26934
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 2
Defective GSIS in mice lacking Vhl in β cells or the pancreas.

(A) Plasma insulin levels before and after an intraperitoneal injection of glucose (3 g/kg body weight) in 12-week-old female control (open squares) and PVhlKO (filled squares) mice. n = 7–9 per genotype. (B and C) Insulin secretion from isolated control (open squares) and βVhlKO islets (closed squares) in response to perifusion with 2 and 20 mmol/l glucose and 500 nmol/l phorbol ester (PMA). n = 3. (D) Insulin secretion from isolated control and PVhlKO islets in static cultures in response to 2 and 20 mmol/l glucose. n = 5. (E) Insulin secretion from isolated control and βVhlKO islets in static cultures in response to 2 and 20 mmol/l glucose, 10 mmol/l α-ketoisocaproic acid (αKIC), and 25 mmol/l potassium chloride (KCl). n = 8. **P < 0.01.